.
├─adjuvanted_oil_influenza_pandemic_vaccine
│    ├─oil_influenza_water_seasonal_adjuvanted
│    │    ├─■──oil_water oil_freund_water_emulsion ── Topic: 4
│    │    └─influenza_seasonal_mf59_adjuvanted_adjuvanted influenza
│    │         ├─■──seasonal_seasonal influenza_influenza_elderly_mf59 ── Topic: 5
│    │         └─■──clade_repertoire_antibody repertoire_diversity affinity_affinity ── Topic: 7
│    └─ferrets_adjuvanted_adjuvanted vaccine_neutralizing antibodies_cross -
│         ├─■──ferrets_cross_neutralizing antibodies_cross -_induces ── Topic: 14
│         └─■──positive_benefit risk_risk profile_age years_narcolepsy ── Topic: 13
└─vaccine_vaccines_cpg_aluminum_adjuvant
     ├─cpg_flagellin_phase_vaccine_dmlt
     │    ├─flagellin_coli_dmlt_immunoge- nicity_safety immunoge-
     │    │    ├─■──flagellin_recombinant_influenza vaccine_tlr-5_response elderly ── Topic: 17
     │    │    └─■──dmlt_coli_oral_double_inactivated ── Topic: 16
     │    └─cpg_plasmodium_stage_alhydrogel cpg_alhydrogel
     │         ├─■──cpg_small_cancer_expert_evaluation efficacy ── Topic: 12
     │         └─■──cpg_alhydrogel cpg_alhydrogel_stage_blood ── Topic: 8
     └─vaccine_vaccines_aluminum_clinical_adjuvant
          ├─vaccine_aluminum_vaccines_clinical_rts
          │    ├─■──relies_vaccines second_matrix_m_future ── Topic: 18
          │    └─vaccine_aluminum_vaccines_rts_adjuvants
          │         ├─aluminum_vaccine_vaccines_adjuvants_mpl
          │         │    ├─clinical trial_vaccine_safety_clinical_events
          │         │    │    ├─■──strains_hpv_clinical trial_clinical_demonstrated acceptable ── Topic: 11
          │         │    │    └─■──safety evaluation_adju- vants_vants_events_safety ── Topic: 6
          │         │    └─aluminum_vaccines_adjuvants_vaccine_adjuvant
          │         │         ├─live_vaccines_adjuvants_human papil-_hpv)-16/18 as04
          │         │         │    ├─■──lomavirus_hpv)-16/18_analysis_agonist vaccine_papil- ── Topic: 3
          │         │         │    └─■──live_vaccines_cmi_immunity_adjuvants ── Topic: 0
          │         │         └─aluminum_salts_mpl_aluminum salts_vaccines containing
          │         │              ├─■──aluminum_salts_aluminum salts_aluminum containing_freezing ── Topic: 2
          │         │              └─■──mpl_sparing_dose sparing_pertussis_combination ── Topic: 15
          │         └─■──rts_rts s_s_date_dren randomized ── Topic: 19
          └─virosomes_polymer_polymers_ethylene_membrane
               ├─virosomes_polymer_polymers_ethylene_membrane
               │    ├─■──polymer_ethylene_polymers_cationic_properties.142 little ── Topic: 9
               │    └─■──virosomes_membrane_licensed_peptides_liposomal membrane ── Topic: 10
               └─■──____ ── Topic: 1
